A randomized phase III trial of S-1 versus S-1 plus irinotecan in advanced gastric cancer.
Not Applicable
- Conditions
- Advanced gastric cancer
- Registration Number
- JPRN-jRCT1080220081
- Lead Sponsor
- Yakult Honsha Co., Ltd. ,DAIICHI SANKYO Co.,Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Histologically confirmed unresectable or relapsed gastric cancer
Neither prior chemotherapy nor prior radiotherapy
Age between 20 and 75 years old
ECOG Performance Status: 0-2
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall survival
- Secondary Outcome Measures
Name Time Method